Roles of UDP-Glucuronosyltransferases in Chemical Carcinogenesi

References

• Armstrong R. N. Enzyme-catalyzed detoxication reactions: Mechanisms and stereochemistr. Crit. Rev. Biochem. 1987; 22: 39
   PubMed Web of Science ®Google Scholar
• Mannervik B., Danielson U. H. Glutathione transferases—structure and catalytic activit. Crit. Rev. Biochem. 1988; 23: 283
   PubMed Web of Science ®Google Scholar
• Coles B., Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesi. Crit. Rev. Biochem. Mol. Biol. 1990; 25: 47
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Enzymatic oxidation of xenobiotic chemical. Crit. Rev. Biochem. Mol. Biol. 1990; 25: 97
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecule. Cancer 1981; 47: 2327
   PubMed Web of Science ®Google Scholar
• Lorentzen R. J., Ts'o P. O. P. Benzo-(a)pyrenedione/benzo(a)pyrenediol oxidation-reduction couples and the generation of reactive reduced molecular oxyge. Biochemistry 1977; 16: 1467
   PubMed Web of Science ®Google Scholar
• Lorentzen R. J., Lesko S. A., McDonald K., Ts'o P. O. P. Toxicity of metabolic benzo-(a)pyrenediones to cultured cells and the dependence upon molecular oxyge. Cancer Res. 1979; 39: 3194
   PubMed Web of Science ®Google Scholar
• Lilienblum W., Back-Hennig B. S., Back K. W. Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronid. Mol. Pharmacol. 1985; 27: 451
   PubMed Web of Science ®Google Scholar
• Shinohara A., Saito K., Yamazoe Y., Kamataki T., Kato R. Acetyl coenzyme A dependent activation of N-hydroxy derivates of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificit. Cancer Res. 1989; 46: 4362
   Google Scholar
• Miller A., Miller E. C. Electrophilic sulfuric acid ester metabolites as ultimate carcinogens, in Biological Reactive Intermediates II. Advances in Experimental Medicine and Biology 1986; 197: 583
   PubMedGoogle Scholar
• Wiseman R. W., Stowers S J., Miller E. C., Anderson M. W., Miller J. A. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3F, mous. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 5825
   PubMed Web of Science ®Google Scholar
• Bishop J. M. Retroviruses and cancer gene. Adv. Cancer Res. 1982; 37: 1
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. Oncogenes of spontaneous and chemically induced tumor. Adv. Cancer Res. 1982; 36: 149
   PubMed Web of Science ®Google Scholar
• Zarbl H., Sukumar S., Arthur A. V., Martin-Zanca D., Barbacid M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rat. Nature 1985; 315: 382
   PubMed Web of Science ®Google Scholar
• Land H., Parada L. F., Weinberg R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogene. Nature 1983; 304: 596
   PubMed Web of Science ®Google Scholar
• Knudson A. G. Mutation and cancer, oncogenes, and antioncogene. Cancer Res. 1985; 45: 1437
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. Finding the anti-oncogen. Sci. Amer. 1988; 34
   Google Scholar
• Moolgavkar S. H. Multistage models for cancer risk assessmen. Biologically Based Methods for Cancer Risk Assessment, C. T. Travis. Plenum Press, New York 1989; 9
   Google Scholar
• Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesi. Science 1990; 249: 1007
   PubMed Web of Science ®Google Scholar
• Schwarz M., Pearson D., Port R., Kunz W. Promoting effect of 4-dimethylaminoazobenzene on enzyme altered foci induced in rat liver by N-nitroso-diethanolamin. Carcinogenesis 1984; 5: 725
   PubMed Web of Science ®Google Scholar
• Rabes H. M. Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogen. J. Cancer Res. Clin. Oncol. 1983; 106: 85
   PubMed Web of Science ®Google Scholar
• Farber E. Cellular biochemistry of the stepwise development of cancer with chemical. Cancer Res. 1984; 44: 5463
   PubMed Web of Science ®Google Scholar
• Poland A., Knutson J. C. 2,3,7,8-Tetrach-lorodibenzo-p-dioxin and related halogenated hydrocarbons: examination of the mechanism of toxicit. Ann. Rev. Pharmacol. Toxicol. 1982; 22: 517
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Petersen D. D., Fornace A. J., Jr. Cellular responses to oxidative stress: the [Ah] gene battery as a paradig. Env. Health Persp. 1990; 88: 13
   PubMed Web of Science ®Google Scholar
• Beland F. A., Kadlubar F. F. Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbon. Chemical Carcino-genesis und Mutagenesis I, C. S. Cooper, P. L. Grover. Springer-Verlag, Berlin 1990; 267
   Google Scholar
• Rehn L. Blasengeschwülste bei Fuchsin-Arbeiter. Arch. Klin. Chir. 1895; 50: 588
   Google Scholar
• Hueper W. C, Wiley F. H., Wolfe H. D., Ranta K. E., Leming M. F., Blood F. R. Experimental production of bladder tumors in dogs by administration of β-naphthylamin. J. Ind. Hyg. Toxicol. 1938; 20: 46
   Google Scholar
• Patrianakos C., Hoffmann D. Chemical studies on tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smok. J. Anal. Toxicol. 1979; 3: 150
   Web of Science ®Google Scholar
• Wynder E. L., Goldsmith R. The epidemiology of bladder cancer. A second loo. Cancer 1977; 40: 1246
   PubMed Web of Science ®Google Scholar
• Moolgavkar S. H., Stevens R. G. Smoking and cancers of bladder and pancreas: risks and temporal trend. J. Natl. Cancer Inst. 1981; 67: 15
   PubMedGoogle Scholar
• Mommsen S., Aagaard J. Tobacco as a risk factor in bladder cance. Carcinogenesis 1983; 4: 335
   PubMed Web of Science ®Google Scholar
• Sugimura T. Past, present, and future of mutagens in cooked food. Environ. Health Perspect. 1986; 67: 5
   PubMed Web of Science ®Google Scholar
• Tokiwa H., Ohnishi Y. Mutagenicity and car-cinogenicity of nitroarenes and their sources in the environmen. CRC Crit. Rev. Toxicol. 1986; 17: 23
   PubMed Web of Science ®Google Scholar
• Silverman D. T., Hoover R. N., Albert S., Graff K. M. Occupation and cancer of the lower urinary tract in Detroi. J. Natl. Cancer Inst. 1983; 70: 237
   PubMedGoogle Scholar
• Wilson R. H., DeEds F., Cox A. J., Jr. The toxicity and carcinogenic activity of 2-acetaminofluoren. Cancer Res. 1941; 1: 595
   Google Scholar
• Kadlubar F. F., Miller J. A., Miller E. C. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesi. Cancer Res. 1977; 37: 805
   PubMed Web of Science ®Google Scholar
• Radomski J. L., Hearn W. L., Radomski T., Moreno H., Scott W. E. Isolation of the glucuronic acid conjugate of N-hydroxy-4-aminobiphenyl from dog urine and its mutagenic activit. Cancer Res. 1977; 37: 1757
   PubMed Web of Science ®Google Scholar
• Poupko J. M., Hearn W. L., Radomski J. L. N-Glucuronidation of N-hydroxy aromatic amines: a mechanism for their transport and bladder-specific carcinogenicit. Toxicol. Appl. Phurmucol. 1979; 50: 479
   PubMed Web of Science ®Google Scholar
• Kadlubar F. F., Unruh L. E., Flammang T. J., Sparks D., Mitchum R. K., Mulder G. J. Alteration of urinary levels of the carcinogen, N-hydmxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretio. Chem.-Biol. Interact. 1981; 33: 129
   PubMed Web of Science ®Google Scholar
• Talaska G., Dooley K. L., Kadlubar F. F. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-amino-biphenyl-treated dogs by 32P-postlabeling and subsequent thin-layer and high-pressure liquid chromatograph. Carcinogenesis 1990; 11: 639
   PubMed Web of Science ®Google Scholar
• Radomski J. L., Deichmann W. B., Altman N. H., Radomski T. Failure of pure 1-na-phthylamine to induce bladder tumors in dog. Cancer Res. 1980; 40: 3537
   PubMed Web of Science ®Google Scholar
• Purchase I. F. H., Kalinowski A. E., Ishmael J., Wilson J., Gore C. W., Chart I. S. Lifetime carcinogenicity study of 1– and 2-napthy-lamine in dog. Br. J. Cancer 1981; 44: 892
   PubMed Web of Science ®Google Scholar
• Lilienblum W., Bock K. W. N-Glucuronide formation of carcinogenic aromatic amines in rat and human liver microsome. Biochem. Pharmacol. 1984; 33: 2041
   PubMed Web of Science ®Google Scholar
• Weisburger J. H. Colon carcinogens: their metabolism and mode of actio. Cancer 1971; 28: 60
   PubMed Web of Science ®Google Scholar
• Luks H. J., Spratt T. E., Vavrek M. T., Roland S. F., Weisburger J. H. Identification of sulfate and glucuronic acid conjugates of the 5-hydroxy derivative as major metabolites of 2-amino-3-meth-ylimidazo[4,5-f]quinoline in rat. Cancer Res. 1989; 49: 4407
   PubMed Web of Science ®Google Scholar
• Turesky R. J., Bracco-Hammer I., Markovlc J., Richli U., Kappeler A.-M., Welti D. H. The contribution of N-oxidation to the metabolism of the food-borne carcinogen 2-amino-3,8-dimethy-limidazo[4,5-f]quinoxaline in rat hepatocyte. Chem. Res. Toxicol. 1990; 3: 524
   PubMed Web of Science ®Google Scholar
• Chipman J. K., Frost G. S., Hirom P. C., Millburn P. Biliary excretion, systemic availability and reactivity of metabolites following intraportal infusion of [3H]benzo[a]pyrene in the ra. Carcinogenesis 1981; 2: 741
   PubMed Web of Science ®Google Scholar
• Renwick A. G., Drasar B. S. Environmental carcinogens and large bowel cance. Nature 1976; 263: 234
   PubMed Web of Science ®Google Scholar
• Kinoshita N., Gelboin H. V. P-Glucuronidase catalysed hydrolysis of benzo[a]pyrene-3-glucuron-ide and binding to DN. Science 1978; 199: 307
   PubMed Web of Science ®Google Scholar
• Conney A. H. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycy-clic aromatic hydrocarbons: G.H.A. Clowes Memorial Lectur. Cancer Res. 1982; 42: 4875
   PubMed Web of Science ®Google Scholar
• Hall M., Grover P. L. Polycyclic aromatic hydrocarbons: metabolism, activation and tumour initiatio. Chemical Carcinogenesis and Mutagenesis I, C. S. Cooper, P. L. Grover. Springer-Verlag, Berlin 1990; 327
   Google Scholar
• Burke M. D., Vadi H., Jernstroijm B., Orrenius S. Metabolism of benzo[a]pyrene with isolated hepatocytes and the formation and degradation of DNA-binding derivate. J. Biol. Chem. 1977; 252: 6424
   PubMed Web of Science ®Google Scholar
• Bock K. W., Bock-Hennig B. S., Lilienblum W., Volp R. F. Release of mutagenic metabolites of benzo(a)pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamid. Chem.-Biol. Interactions 1981; 36: 167
   PubMed Web of Science ®Google Scholar
• Owens I. S., Koteen G. M., Legraverend C. Mutagenesis of certain benzo[a]pyrene phenols in vitro following further metabolism by mouse live. Biochem. Pharmacol. 1979; 28: 1615
   PubMed Web of Science ®Google Scholar
• Bock K. W., Bock-Hennig B. S., Fischer G., Lilienblum W., Ullrich D. Role of glucuronidation and sulfation in the control of reactive metabolite. Biochemical Basis of Chemical Carcinogenesis, Thirteenth Workshop Conference Hoechst, H. Greim, R. Jung, M. Kramer, H. Marquardt, F. Oesch. Raven Press, New York 1984; 13
   Google Scholar
• Nemoto N., Takayama S., Nagao M., Umezawa K. Modification of the mutagenicity of benzo(a)pyrene on bacteria by substrates of enzymes producing water soluble conjugate. Toxicol. Lett. 1978; 2: 205
   Web of Science ®Google Scholar
• Malaveille C., Brun G., Hautefeuille A., Bartsch H. Effect of glutathione and uridine 5′-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assa. Mechanisms of Toxicity and Hazard Evaluation, B. Holmstedt, R. Lauwreys, M. Mercier, M. Roberfroid. Elsevier, Amsterdam 1980; 175
   Google Scholar
• Bock K. W., Lipp H.-P., Bock-Hennig B. S. Induction of drug-metabolizing enzymes by xenobiotic. Xenobiotica 1990; 20: 1101
   PubMed Web of Science ®Google Scholar
• Shen A. L., Fahl W. E., Wrighton S. A., Jefcoate C. R. Inhibition of benzo[a]pyrene and benzo[a]pyrene quinone. Cancer Res. 1979; 39: 4123
   PubMed Web of Science ®Google Scholar
• Bock K. W. Increase of liver microsomal benzo(a)pyrene monooxygenase activity by subsequent glucumnidatio. Naunyn-Schmiedeberg's Arch. Pharmacol. 1978; 304: 77
   Google Scholar
• Back K. W.v., Clausbruch U. C., Kaufmann R., Lilienblum W., Oesch F., Pfeil H., Platt K. L. Functional heterogeneity of UDP-glucuron-yltransferase in rat tissue. Biochem. Pharmacol. 1980; 29: 495
   PubMedGoogle Scholar
• Segura-Aquilar J. E., Barreiro V., Lind C. Dicoumarol-sensitive glucuronidation of benzo(a)pyrene metabolites in rat liver microsome. Arch. Biochem. Biophys. 1986; 251: 266
   PubMed Web of Science ®Google Scholar
• Tunek A., Platt K. L., Bentley P., Oesch F. Microsomal metabolism of benzene to species irreversibly binding to microsomal protein and effects of modifications of this metabolis. Mol. Pharmacol. 1978; 14: 920
   PubMed Web of Science ®Google Scholar
• Greenlee W. F., Irons R. D. Modulation of benzene-induced lymphocytopenia in the rat by 2,4,5,2′,4′,5′-hexachlorobiphenyl and 3,4,3′,4′-tetrachlorobipheny. Chem.-Biol. Interact. 1981; 33: 345
   PubMed Web of Science ®Google Scholar
• Sammett D., Lee E. W., Kocsis J. J., Snyder R. Partial hepatectomy reduces both metabolism and toxicity of benzen. J. Toxicol. Environ. Health 1979; 5: 785
   PubMed Web of Science ®Google Scholar
• Schrenk D., Back K. W. Metabolism of benzene in rat hepatocytes: influence of inducers on phenol glucuronidatio. Drug Metab. Disp. 1990; 18: 720
   PubMed Web of Science ®Google Scholar
• Reitz R. H., Fox T. R., Quast J. F., Hermann E. A., Watanabe P. G. Molecular mechanisms involved in the toxicity of oxihophenylphenol and its sodium sal. Chem.-Biol. Interact. 1983; 43: 99
   PubMed Web of Science ®Google Scholar
• Cardona R. A., King C. M. Activation of the O-glucuronide of the carcinogen N-hydroxy-N-2-fluorenylacetamide by enzymatic deacetylation in vitro: formation of fluorenylamine-tRNA adduct. Biochem. Pharmacol. 1975; 25: 1051
   Web of Science ®Google Scholar
• Irving C. C. Influence of the aryl group on the reaction of glucuronides of N-arylacethydroxamic acids with polynucleotide. Cancer Res. 1977; 37: 524
   PubMed Web of Science ®Google Scholar
• Wang C. Y., Christensen B., Zukowski K., Morton K. C., Lee M. S. Induction of DNA repair synthesis in human urothelial cells by the N-hydroxy metabolites of carcinogenic arylamine. J. Natl. Cancer Inst. 1984; 72: 847
   PubMedGoogle Scholar
• Wang C. Y., Zukowski K., Lee M. S. Glucuronidation of carcinogenic arylamine metabolites by rat liver microsome. Biochem. Pharmacol. 1985; 34: 837
   PubMed Web of Science ®Google Scholar
• Splewak Rinaudo J. A., Eriksson L. C., Roomi M. W., Farber E. Kinetics of excretion of 2-acetylaminofluorene in normal and xenobiotic-treated rats and in rats with hepatocyte nodule. Lab. Invest. 1989; 60: 399
   PubMed Web of Science ®Google Scholar
• Bock-Hennig B. S., Ullrich D., Bock K. W. Activating and inactivating reactions controlling 2-naphthylamine mutagenicit. Arch. Toxicol. 1982; 50: 259
   PubMed Web of Science ®Google Scholar
• Monteith D. K., Michalopoulos G., Strom S. C. Conjugation of chemical carcinogens by primary cultures of human hepatocyte. Xenobiotica 1990; 20: 753
   PubMed Web of Science ®Google Scholar
• Wang C. Y., Zukowski K., Lee M A, Imaida K. Production of urothelial tumors in the heterotopic bladder of rats by installation of N-glucuronosyl or N-acetyl derivates of N-hydroxy-2-ami-nofluoren. Cancer Res. 1987; 47: 3406
   PubMed Web of Science ®Google Scholar
• Mulder G. J., Hinson J. A., Gillette J. R. Conversion of the N-O-glucuronide and N-O-sulfate conjugates of N-hydroxyphenacetin to reactive intermediate. Biochem. Pharmacol. 1978; 27: 1641
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Andrews L. S., Gillette R. Kinetic evidence for multiple chemically reactive intermediates in the breakdown of phenacetin N-O-glucumnid. Pharmacology 1979; 19: 237
   PubMed Web of Science ®Google Scholar
• Camus A.-M., Friesen M., Croisy A., Bartsch H. Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urin. Cancer Res. 1982; 42: 3201
   PubMed Web of Science ®Google Scholar
• Feng P. C. C., Fenselau C., Colvin M. E., Hinson J. A. Synthesis and analysis of glucuronides of N-hydroxyamide. Drug Metab. Disp. 1983; 11: 103
   PubMed Web of Science ®Google Scholar
• Lynn R. K., Garvie-Gould C. T., Milam D. F., Scott K. F., Eastman C. L., Ilias A. M., Rodgers R. M. Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolite. Toxicol. Appl. Pharmacol. 1984; 72: 1
   PubMed Web of Science ®Google Scholar
• Cellular and Molecular Aspects of Glucuronidation, G. Siest, J. Magdalou, B. Burchell. John Libbey Eurotext. 1990, Colloque INSERM 173
   Google Scholar
• Mulder G. J., Coughtrie M. W. H., Burchell B. Glucuronidatio. Conjugation Reactions in Drug Metabolism, G. J. Mulder. Taylor and Francis. 1990; 51
   Google Scholar
• Bock K. W., White I. N. H. UDP-glucuronyltransferase in perfused rat liver and in microsomes: influence of phenobarbital and 3-methylcholanthren. Eur. J. Biochem. 1974; 46: 451
   PubMedGoogle Scholar
• Ullrich D., Bock K. W. Glucuronide formation of various drugs in liver microsomes and in isolated hepatocytes from phenobarbital- and 3-meth-ylcholanthrene-treated rat. Biochem. Pharmacol. 1984; 33: 97
   PubMed Web of Science ®Google Scholar
• Iyanagi T., Haniu M., Sogawa K. Fujii-Kuriyama, Y., Watanabe, S., Shively, J. E., and Anan, K. F., Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltferas. J. Biol. Chem. 1986; 261: 15607
   PubMed Web of Science ®Google Scholar
• Mackenzie P. I., Chowdhury N. R., Chowdhury J. R. Characterization and regulation of rat liver UDP glucuronosyltransferase. Clin. Exp. Pharmacol. Physiol. 1989; 16: 501
   PubMed Web of Science ®Google Scholar
• Hauser S. C., Ziurys J. C., Gollan J. L. A membrane transporter mediates access of uridine 5′-diphosphoglucuronic acid from the cytosol into the endoplasmic reticulum of rat hepatocytes: implications for glucuronidation reaction. Biochem. Bio-phys. Acta 1988; 967: 149
   PubMed Web of Science ®Google Scholar
• Vanstapel F., Blanckaert N. Topology and regulation of bilirubin UDP-glucuronyltransferase in sealed native microsomes from rat live. Arch. Biochem. Biophys. 1988; 263: 216
   PubMed Web of Science ®Google Scholar
• Bock K. W., Fröhling W., Remmer H., Rexer B. Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver mi-crosomal UDP-glucuronyltransferas. Biochim. Biophys. Acta 1973; 327: 46
   PubMed Web of Science ®Google Scholar
• Lucier G. W., McDaniel O. S., Hook G. E. R. Nature of the enhancement of hepatic uridine diphosphate glucuronyl-transferase activity by 2,3,7,8-temhlorodibenzo-p-dioxin in rat. Biochem. Pharmacol. 1975; 24: 325
   PubMed Web of Science ®Google Scholar
• Wishart G. J. Demonstration of functional heterogeneity of hepatic uridine diphosphate glucuronosyltransferase activities after administration of 3-methylcholanthrene and phenobarbital to rat. J. Biochem. 1978; 174: 671
   Google Scholar
• Lilienblum W., Walli A. K., Bock K. W. Differential induction of rat liver microsomal UDP-glucuronosyltransferase activities by various inducing agent. Biochem. Pharmacol. 1982; 31: 907
   PubMed Web of Science ®Google Scholar
• Bock K. W., Josting D., Lilienblum W., Pfeil H. Purification of rat liver microsomd UDP-glucuronyl-transferas. Eur. J. Biochem. 1979; 98: 19
   PubMedGoogle Scholar
• Falany C. N., Tephly T. R. Separation, purification and characterization of three isoenzymes of UDP-glucuronosyltransferase from rat liver microsome. Arch. Biochem. Biophys. 1983; 227: 248
   PubMed Web of Science ®Google Scholar
• Bock K. W., Schirmer G., Green M. D., Tephly T. R. Properties of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase from rat live. Biochem. Pharmacol. 1988; 37: 1439
   PubMed Web of Science ®Google Scholar
• Sato H., Koiwai O., Tanabe K., Kashiwamata S. Isolation and sequencing of rat liver bilirubin UDP-glucuronosyltransferase cDNA: possible alternate splicing of a common primary transcrip. Biochem. Biophys. Res. Commun. 1990; 169: 260
   PubMed Web of Science ®Google Scholar
• Scragg I., Celier C., Burchell B. Congenital jaundice in rats due to the absence of hepatic bilirubin UDP-glucuronyltransferase enzyme protei. FEBS Lett. 1985; 183: 37
   PubMed Web of Science ®Google Scholar
• Roy Chowdhury J., Roy Chowdhury N., Falany C. N., Tephly T. R., Arias I. M. Isolation and characterization of multiple forms of rat liver UDP-glucuronate glucuronosyltransferas. Biochem. J. 1986; 233: 827
   PubMed Web of Science ®Google Scholar
• von Meyerinck L., Coffman B. L., Green M. D., Kirkpatrick R. B., Schmoldt A., Tephly T. R. Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activit. Drug Metab. Dispos. 1985; 13: 700
   PubMed Web of Science ®Google Scholar
• Puik J. F., Tephly T. R. Isolation and purification of rat liver morphine UDP-glucuronosyltransferas. Mol. Pharmacol. 1986; 30: 558
   PubMed Web of Science ®Google Scholar
• Mackenzie P. I. Rat liver UDP-glucuronosyltransferase. Identification of cDNAs encoding two enzymes which glucuronidate testosterone, dihydrotestosterone and β-estradio. J. Biol. Chem. 1987; 262: 9744
   PubMed Web of Science ®Google Scholar
• Mackenzie P. I., Rodbourn L. Organization of the rat UDP-glucuronosyltransferase, UDPGTr-2, gene and characterization of its promote. J. Biol. Chem. 1990; 265: 11328
   PubMed Web of Science ®Google Scholar
• Harding D., Wilson S. M., Jackson M. R., Burchell B., Green M. D., Tephly T. R. Nucleotide and deduced amino acid sequence of rat liver 17β-hydroxysteroid UDP-glucuronosyltransferas. Nucl. Acids Res. 1987; 15: 3936
   PubMedGoogle Scholar
• Jackson M. R., Burchell B. The full length coding sequence of rat liver androsterone UDP-glucuronyltransferase cDNA and comparison with other members of this gene famil. Nucl. Acids Res. 1986; 14: 779
   PubMed Web of Science ®Google Scholar
• Mackenzie P. I. Rat liver UDP-glucuronosyltransferase. Sequence and expression of cDNA encoding a phenobarbital-inducible for. J. Biol. Chem. 1986; 261: 14112
   PubMed Web of Science ®Google Scholar
• Harding D., Fournel-Gigleux S., Jackson M. R., Burchell B. Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expssed in COS-7 cell. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 8381
   PubMed Web of Science ®Google Scholar
• Forster A., Briick M., El Mouelhi M., Fournel-Gigleux S., Siest G., Burchell B., Bock K. W. Paracetamol glucuronidation by human liver phenol UDP-glucuronosyltransferas. Naunyn-Schmiedeberg'sArch. Pharmacol. 1991; 343: R 11
   Google Scholar
• Burchell B., Coughtrie M. W. H., Jackson M. R., Shepherd S. R. P., Harding D., Hume R. Genetic deficiency of bilirubin glucuronidation in rats and human. Molec. Aspects Med. 1987; 9: 429
   PubMed Web of Science ®Google Scholar
• Thomassin J., Styczynski P., Coffman B., Green M., Tephly T. Studies on human liver microsomal morphine and tertiary amine UDP-glucuronosyltransferases: photoaffinity labelling and immunoinhibitio. Hepatic Metabolism and Disposition of Endo- and Xenobiotics, K. W. Bock, W. Gerok, S. Matern, R. Schmid. Kluwer Academic Publishers, Dordrecht 1991, in press
   Google Scholar
• Irshaid Y. M., Tephly T. R. Isolation and purification of two human liver UDP-glucuronosyltransferase. Mol. Pharmucol. 1987; 31: 27
   PubMed Web of Science ®Google Scholar
• Coffman B. L., Tephly T. R., Irshaid Y. M., Green M. D., Smith C., Jackson M. R., Wooster R., Burchell B. Characterization and primary sequence of a human hepatic microsomal estriol UDPglucuronosyltransferas. Arch. Biochem. Biophys. 1990; 281: 170
   PubMed Web of Science ®Google Scholar
• Fournel-Gigleux S., Jackson M. R., Wooster R., Burchell B. Expression of a human liver cDNA encoding a UDP-glucuronosyltransferase catalysing the glucuronidation of hyodeoxycholic acid in cell cultur. FEBS Lett. 1989; 243: 119
   PubMed Web of Science ®Google Scholar
• Ritter J. K., Sheen Y. Y., Owens I. S. Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cell. J. Biol. Chem. 1990; 265: 7900
   PubMed Web of Science ®Google Scholar
• Bock K. W., Burchell B., Dutton G. J., Hänninen O., Mulder G. J., Owens I. S., Siest G., Tephly T. R. Commentary: UDP-glucuronosyltransferase activities: guidelines for consistent interim terminology and assay condition. Biochem. Pharmacol. 1983; 32: 953
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Gonzalez F. J. P450 genes: structure, evolution, and regulatio. Ann. Rev. Biochem. 1987; 56: 945
   PubMed Web of Science ®Google Scholar
• Iyanagi T., Watanabe T., Uchiyama Y. The 3-methylcholanthrene-inducible UDP-glucuronosyltransferase deficiency in the hyperbilintbinemic rat (Gunn rat) is caused by a -1 frameshift mutatio. J. Biol. Chem. 1989; 264: 21302
   PubMed Web of Science ®Google Scholar
• Kimura T., Owens I. S. Mouse UDP-glucuronosyltransferase cDNA and complete amino acid sequence and regulatio. Eur. J. Biochem. 1987; 168: 515
   PubMedGoogle Scholar
• Lazard D., Tal N., Rubinstein M., Kehn M., Lancet D., Zupko K. Identification and biochemical analysis of novel olfactory-specific cytochrome P-450IIA and UDP-glucuronosyl transferas. Biochemistry 1990; 29: 7433
   PubMed Web of Science ®Google Scholar
• Dutton G. J. Glucuronidation of Drugs and Other Compounds. CRC Press, Boca Raton, FL 1980
   Google Scholar
• Lilienblum W., Platt K. L., Schirmer G., Oesch F., Bock K. W. Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities towards phenols of benzo(a)pyrene and dibenzo(a,h)anthracen. Mol. Pharmacol. 1987; 32: 173
   PubMed Web of Science ®Google Scholar
• Green M. D., Tephly T. R. N-glucuronidation of carcinogenic aromatic amines catalyzed by rat hepatic microsomal preparations and purified rat liver uridine 5′ -diphosphate-glucuronosy ltransferase. Cancer Res. 1987; 47: 2028
   PubMed Web of Science ®Google Scholar
• Wolf C. R., Macpherson J. S., Smith J. F. Evidence for the metabolism of mitozantrone by microsomal glutathione transferases and 3-methylcholanthrene-inducible glucuronosyl transferase. Biochem. Pharmacol. 1986; 35: 1577
   PubMed Web of Science ®Google Scholar
• El Mouelhi M., Bock K. W. Stereoselective (S)- and (R)-naproxen glucuronosyltransferase of rat live. DrugMetab. Disp. 1991; 19: 304
   PubMed Web of Science ®Google Scholar
• Bastomsky C. H. Enhanced thyroxine metabolism and high uptake goiters in rats after a single dose of 2,3,7,8-tetracholordibenzo-p-dioxi. Endocrinology 1977; 101: 292
   PubMed Web of Science ®Google Scholar
• Watkins J. B., Gregus Z., Thompson T. N., Klaassen C. D. Induction studies on the functional heterogeneity of rat liver UDP-glucuronosyl-transferase. Toxicol. Appl. Pharmacol. 1982; 64: 439
   PubMed Web of Science ®Google Scholar
• Bock K. W., Kahl R., Lilienblum W. Induction of rat hepatic UDP-glucuronosyltransferase by dietary ethoxyqui. Naunyn-Schmiedeberg's Arch. Pharmacol. 1980; 310: 249
   Google Scholar
• Prochaska H. J., Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine live. Cancer Res. 1988; 48: 4776
   PubMed Web of Science ®Google Scholar
• De Long M. J., Prochaska H. J., Talalay P. Induction of NAD(P)H-quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogen. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 787
   PubMed Web of Science ®Google Scholar
• Rushmore T. H., Pickett C. B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gen. J. Biol. Chem. 1990; 265: 14648
   PubMed Web of Science ®Google Scholar
• Bradfleld C. A., Poland A. A competitive binding assay for 2,3,7,8-tetrachlorodibenzo-p-dixin and related ligands of the Ah recepto. Mol. Pharmacol. 1988; 34: 682
   PubMed Web of Science ®Google Scholar
• Gillner M., Bergman J., Cambillau C., Gustafsson J.-A. Interactions of rutaecarpine alkaloids with specific binding sites for 2,3,7,8-tetrach-lorodibenzo-p-dioxin in rat live. Carcinogenesis 1989; 10: 651
   PubMed Web of Science ®Google Scholar
• Denison M. S., Fisher J. M., Whitlock J. The DNA-recognition site for the dioxin-Ah receptor comple. J. Biol. Chem. 1988; 263: 17221
   PubMed Web of Science ®Google Scholar
• Sogawa K., Fujisawa-Sehara A., Yamane M., Fujii-Kuriyama Y. Location of regulatory elements responsible for drug induction in the rat cytochrome P-450c gen. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 8044
   PubMed Web of Science ®Google Scholar
• Evans R. M. The steroid and thyroid hormone receptor superfamil. Science 1988; 240: 889
   PubMed Web of Science ®Google Scholar
• Owens I. D. Genetic regulation of UDP-glucuronosyl-transferase induction by polycyclic aromatic compounds in mic. J. Biol. Chem. 1977; 252: 2827
   PubMed Web of Science ®Google Scholar
• Schrenk D., Lipp H.-P., Wiesmüller T., Hagenmaier H., Bock K. W. Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins: comparison between defined mixtures and their constituent. Arch. Toxicol. 1991; 65: 114
   PubMed Web of Science ®Google Scholar
• Mucklow J. C., Fraser H. S., Bulpitt C. J., Kahn C., Mould G., Dolery C. T. Environmental factors affecting paracetamol metabolism in London factory and office worker. Br. J. Clin. Pharmacol. 1980; 10: 67
   PubMed Web of Science ®Google Scholar
• Bock K. W., Wiltfang J., Blume R., Ullrich D., Bircher J. Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smokin. Eur. J. Clin. Pharmacol. 1987; 31: 677
   PubMed Web of Science ®Google Scholar
• Hayes J. D., Wolf C. R. Molecular mechanisms of drug resistanc. Biochem. J. 1990; 272: 281
   PubMed Web of Science ®Google Scholar
• Beer D. G., Pitot H. C. Biological markers characterizing the development of preneoplastic and neoplastic lesions in rodent live. Arch. Toxicol. 1987; 68(Suppl. 10)
   Google Scholar
• Fischer G., Ullrich D., Katz N., Bock K. W., Schauer A. Immunohistochemical and biochemical detection of uridine-diphosphate-glucuronosyltransferase (UDP-GT) activity in putative preneoplastic liver foc. Virchows. Arch. 1983; 42: 192
   Web of Science ®Google Scholar
• Fischer G., Ullrich D., Bock K. W. Effects of N-nitrosomorpholine and phenobarbital on UDP-glucuronosyl-transferase in putative pneoplastic foci of rat live. Carcinogenesis 1985; 6: 605
   PubMed Web of Science ®Google Scholar
• Bock K. W., Lilienblum W., Pfeil H., Erlksson L. C. Increased uridine diphosphate-glucuronosyltransferase activity in preneoplastic liver nodules and Morris hepatoma. Cancer Res. 1982; 42: 3747
   PubMed Web of Science ®Google Scholar
• Yin Z., Sato K., Tsuda H., Ito N. Changes in activities of uridine diphosphate-glucuronosyltransferase during chemical hepatocarcinogenesi. Gann 1982; 73: 239
   PubMedGoogle Scholar
• Bock K. W., Kobusch A.-B., Fischer G. Heterogeneous alterations of UDP-glucuronosyltransferases in mouse hepatic foc. J. Cancer Res. Clin. Oncol. 1989; 115: 285
   PubMed Web of Science ®Google Scholar
• Bock K. W., Miinzel P. A., Röhrdanz E., Schrenk D., Eriksson L. C. Persistently increased expression of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinoma. Cancer Res. 1990; 50: 3569
   PubMed Web of Science ®Google Scholar
• Eggens I., Eriksson L. C., Chojnacki T., Dallner G. Role of dolichyl phosphate in regulation of protein glycosylation in 2-acetylaminofluorene-induced carcinogenesis in rat live. Cancer Res. 1984; 44: 799
   PubMed Web of Science ®Google Scholar
• Bock K. W. Conjugation reactions in carcinogen metabolism and their permanent alterations after initiation of hepatocarcinogenesi. Liver Cell Carcinoma, P. Bannasch, D. Keppler, G. Weber. MTP Press, LancasterUK 1989; 251
   Google Scholar
• Ringer D. P., Norton T. R., Howell B. A. 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesi. Cancer Res. 1990; 50: 5301
   PubMed Web of Science ®Google Scholar
• Thorgeirsson S. S., Huber B. E., Sorrell S., Fojo A., Pastan I., Gottesman M. M. Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat live. Science 1987; 236: 1120
   PubMed Web of Science ®Google Scholar
• Sell S. Is there a liver stem cel. Cancer Res. 1990; 50: 3811
   PubMed Web of Science ®Google Scholar
• Evarts R. P., Nagy P., Nakatsukasa H., Marsden E., Thorgeirsson S. S. In vivo differentiation of rat liver oval cells into hepatocyte. Cancer Res. 1989; 49: 1541
   PubMed Web of Science ®Google Scholar
• Hixson D. C., Allison J. P. Monoclonal antibodies recognizing oval cells induced in the liver of rats by N-2-fluorenylacetamide or ethionine in a choline-deficient die. Cancer Res. 1985; 45: 3750
   PubMedGoogle Scholar
• Germain L., Noel M., Gourdeau H., Marceau N. Promotion of growth and differentiation of ductular oval cells in primary cultur. Cancer Res. 1988; 48: 368
   PubMed Web of Science ®Google Scholar
• McMahon J. B., Richards W. L., del Campo A. A., Song M. H., Thorgeirsson S. S. Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in cultur. Cancer Res. 1986; 46: 4665
   PubMed Web of Science ®Google Scholar
• Schrenk D., Eisenmann-Tappe I., Gebhardt R., Mayer D., El Mouelhi M., Röhrdanz E., Münzel P., Bock K. W. Drug metabolizingenzyme activities in rat liver epithelial cells, hepatocytes and bile duct cell. Biochem. Phurmucol. 1991; 41: 1751
   PubMed Web of Science ®Google Scholar
• Cowan K. H., Batist G., Tulpule A., Sinha B. K., Myers C. E. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rat. Proc. Natl. Acad. Sci. U.S.A. 1986; 83: 9328
   PubMed Web of Science ®Google Scholar
• Akman S. A., Forrest G., Fong-Fong C., Esworthy R. C., Doroshow J. H. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cell. Cancer Res. 1990; 50: 1397
   PubMed Web of Science ®Google Scholar
• Gessner T., Vaughan L. A., Beehler B. C., Bartels C. J., Baker R. M. Elevated pentose cycle and glucuronyl-transferase in daunorubicin-resistant P388 cell. Cancer Res. 1990; 50: 3921
   PubMed Web of Science ®Google Scholar
• Peraino C., Carnes B. A., Stevens F. J., Staffeldt E. F., Russell J. J., Rapuolenis A., Blomquist J. A., Vessellnovitch S. D., Maronpot R. R. Comparative developmental and phenotypic properties of altered hepatocyte foci and hepatic tumors in rat. Cancer Res. 1988; 48: 4171
   PubMed Web of Science ®Google Scholar
• Schwarz M., Buchmann A., Schulte M., Pearson D., Kunz W. Heterogeneity of enzyme-altered foci in rat live. Toxicol. Lett. 1989; 49: 297
   PubMed Web of Science ®Google Scholar
• Moore M. A., Mayer D., Bannasch P. The dose dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholin. Carcinogenesis 1982; 3: 1429
   PubMed Web of Science ®Google Scholar
• Campbell H. A., Pitot H. C., Potter V. R., Laishes B. A. Application of quantitative stereology to evaluation of enzyme-altered foci in rat live. Cancer Res. 1982; 42: 465
   PubMed Web of Science ®Google Scholar